TCL Archive Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer April 30, 2004
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review January 12, 1979